Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ma Xing Shi Gan Tang is a classical Chinese herbal formula composed of four main ingredients: Ephedra stem (Ma Huang), Gypsum (Shi Gao), Apricot kernel (Xing Ren), and Honey-fried Licorice root (Zhi Gan Cao)[1][6]. It was first described in the ancient text "On Cold Damage" (Shang Han Lun) around 220 AD[1][6]. The formula is traditionally used to clear heat from the lungs, facilitate the flow of Lung Qi, stop cough and wheezing by directing rebellious Qi downward[1][4][6]. Its primary indications include symptoms such as high fever with or without sweating, thirst with dry throat, cough with thin yellow sputum or labored breathing/wheezing—often associated with conditions like upper respiratory tract infections and pneumonia[1][3][6]. Modern research has shown that Ma Xing Shi Gan Tang exhibits antibacterial activity against pathogens such as Streptococcus pneumoniae by targeting pneumolysin—a key virulence factor—suggesting a mechanism involving inhibition of bacterial toxins in addition to its traditional anti-inflammatory effects[3]. The formula is sometimes used for bronchial asthma and other lung heat syndromes in both adults and children[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ma Xing Shi Gan Tang.